Israel Englander Rocket Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 105,325 shares of RCKT stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,325
Previous 20,000
426.63%
Holding current value
$2.12 Million
Previous $538,000
321.38%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$357 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$185 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$117 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$87.3 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.53B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...